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by Renate D. Kimbrough*
Similar qualitative toxic effects have been observed in animals for a class of halogenated aromatic
compounds, which include the halogenated biphenyls, naphthalenes, dibenzodioxins, and dibenzofurans.
All of these compounds are lipid soluble and persist in the environment and in mammals. The
polybrominated biphenyls (PBBs) are the most persistent. They are predominantly stored in fatty tissue;
they pass the placenta and are excreted in milk. Some isomers ofthe halogenated biphenyls are more toxic
than others. With some exceptions, the more toxic isomers are retained longer in tissues and are also the
carcinogenic components ofthe mixture. Most ofthese chemicals seem to be promoters ofcarcinogenesis
in animals rather than initiators. An array oftoxic effects in laboratory animals has been ascribed tothese
compounds and numerous reviews summarizing this information are available. Less information is
available on the human health effects of environmental and occupational exposure. Results of recent
studies in animals to further elucidate the effects ofthese chemicals are presented, and results from some
human studies conducted in the United States are reviewed.
Introduction
Concern about the chronic toxicity of organic chlori-
nated chemicals developed only in the last two decades
(1). It was established in the 1950s that 1,1'-(2,2,2-tri-
chloroethylidene)bis(4-chlorobenzene) (DDT) was re-
tained in tissues (2), but this retention was not really
considered to be harmful. The persistence ofpolychlori-
nated biphenyls (PCBs) in the environment was recog-
nized in 1966 by Jensen (3), and 2,3,7,8-tetrachloro-
dibenzodioxin was first identified in 1957 (4). During
this time, these types of chemicals were increasingly
produced, and they and their wastes began to enter the
environment (5). Around 1970, a chemical company in
Michigan manufactured the brominated biphenyls as
flame retardants. This same company also produced
magnesium oxide, achemical commonly mixed into feed
forlivestock. Theflame retardant was called Firemaster
and the magnesium oxide, Nutrimaster. In 1973 some
bags of Firemaster were accidentally sold as Nutri-
master and mixed into animal feed; this resulted in
widespread contamination in the State of Michigan (6).
The production ofbrominated biphenyls has since been
discontinuedinthe United States. The Michiganpopula-
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tion has also been exposed to PCBs. Similarly, in a
recently completed study (7,8) in apredominantly black
population with exposure to high levels ofDDTresidues
through the consumption ofcontaminated fish, elevated
blood PCB levels were noted. Thus, in studying such
population, multiple chemical exposure is usually
encountered. As our analytical capabilities improve,
chlorinated dibenzodioxins and dibenzofurans are de-
tected in our environment with increasing frequency.
As in the case of polybrominated biphenyls (PBBs),
little is usually known about the health effects ofthese
chemicals when human exposure first occurs, nor, in
every instance, are the combined effects of these
different types of chemicals known. For these reasons,
animal studies are begun at this point. If the animal
studies suggest that the chemicals in question might,
indeed, cause chronic health effects in humans, much
energy is devoted to refuting the results. It would be
more fruitful to try to determine, in unintentionally
exposed populations, whether similar effects might
occur. Because of the long life span in humans, such
studies are difficult and expensive, and they do not
provide quick answers. However, to elucidate the
significance oflaboratory animal studies, it is extremely
important to determine whether chronic health effects
occur in populations accidentally or occupationally ex-
posed to these chemicals. It is equally important toR. D. KIMBROUGH
recognize the limitations of such studies and to design
them so that the results are meaningful.
Animal Studies
General
The chlorinated biphenyls, dibenzodioxins and furans
have, as a group, been shown to affect reproduction,
suppress the immune response, cause tumors in labora-
tory rodents, produce hepatic porphyria and cause chick
edema in chickens. In the nonhuman primate, the
rabbit, the horse, cattle and the hairless mouse, skin
lesions can be produced which primarily involve hair
follicles and Meibomian glands. The hair follicles dilate
and fill with keratin, and the sebaceous glands atrophy.
In addition, a variety of biochemical effects have been
determined, and microsomal enzymes may be induced
not only in the liver but also in other organs.
Not all animal species respond to these chemicals in
the same way, nor do those organs showing the highest
tissue concentrations of these compounds necessarily
show the most pathology. In addition, different species
vary in their susceptibility to the damaging effects of
these chemicals. The monkey, guinea pig, and the mink
are affected at much lower dosage levels than the rat,
hamster and mouse. All ofthese chemicals are retained
in the body for extended periods. A number ofreviews
on the toxicity ofthese compounds have appeared, and
this information was summarized recently (1,9,10).
As far as chronic human health effects are concerned,
the questions of whether these chemicals are car-
cinogenic, whether they are immunotoxic, and whether
they affect reproduction are extremely important.
Further, recent experimental evidence suggests that
they may cause lipid peroxidation (11).
Both PBBs and PCBs are a mixture of chemicals.
Within the last few years much progress has been made
in characterizing these mixtures. It is now known that
some isomers of these mixtures are much more toxic
than others. The more toxic isomers are, generally, also
the more persistent, both in the environment and in
living organisms (12-14). Since PCBs were found usu-
ally to contain trace amounts of chlorinated dibenzo-
furans, some investigators have postulated that the
toxic effects resulting from technical PCBs are caused
by the chlorinated dibenzofurans. More recent research
suggests that some PCB congeners are quite toxic by
themselves. Thus, in comparing the toxicity of PCB
mixtures, it is important to establish not only the
concentration of chlorinated dibenzofurans in the mix-
ture, but also the isometric composition ofthe mixture.
All of these chemicals are lipid soluble and are,
therefore, primarily retained in adipose tissue, but they
can also be measured in serum, at lower concentrations
than in adipose tissue or in other organs. They pass the
placenta and are primarily excreted through bile and
milk. The ratios between adipose tissue, blood, and
vital organs vary a great deal and are influenced by
exposure level, sex, age, lipid content, length of
exposure, and whether exposure is current. Further-
more, at very low concentrations, an analytical impreci-
sion influences the ratio much more than at higher
concentrations. Polarityalsoaffectspartitioning(15,16).
Immunotoxicity
There are two distinct but not entirely independent
systems of immunity, the cell-mediated immunity and
the humoral immunity (17). The cell-mediated immu-
nity includes the following processes: the classical
cell-mediated immunity against fungi, viruses and
bacteria; the delayed-type hypersensitivity (e.g., tuber-
culin hypersensitivity); and the rejection oftumors and
foreign tissue, such as transplants, and the allogenic
(graft vs. host) diseases. The other system is the
humoral immunity which operates through antibody-
producing cells.
Neonatal thymectomy or radiation of the thymus
impairs cell-mediated immune responses. The haloge-
nated aromatic compounds discussed here are now
thought to have a similar effect. In the guinea pig, the
developing and the adult animal seem to be quite
sensitive to this effect, but in other species, young
animals are much more susceptible. 2,3,7,8-Tetrachloro-
dibenzo-p-dioxin (TCDD) has beenthe mostextensively
studied representative of this group. Guinea pigs ex-
posed to as little as 40 ngTCDD/kgbody weight weekly
for 8 weeks had depressed delayed hypersensitivity
reaction to tuberculin (18). The graft versus host
reactionwas suppressed afterdosages of0.5 ,ug/kgbody
weight weekly for 4 weeks.
Sharma et al. (19) reported that a number ofimmuno-
logical parameters were affected in mice and rabbits at
dosage levels ofless than 1 ,ug/kg/weekfor 8 weeks. The
effects are more severe when the chemical is adminis-
tered during both the prenatal and postnatal periods
than during the postnatal period alone (20-22).
The expermental results for PCBs are not as clear-
cut(23).
Both the cell-mediated and humoral immune re-
sponses were affected in some studies but not in others.
The dosages of commercial PCB mixtures employed
ranged from 0.3 mg to as much as 1000 mg/kg body
weight. The differences in response are at least partly
causedbydifferencesinthecompositionofthemixtures.
Isomers such as 3,4,3',4'-tetrachlorobiphenyl, 3,4,5,
3',4' 5'-hexachlorobiphenyl and 3,4,5,3',4'-pentachloro-
biphenyl are known to cause atrophy ofthe thymus and
spleen in- rodents. A pronounced immunotoxic effect
depends most likely on the presence of these types of
chemicals in the mixture (24).
Similarly, the PBB mixture contains isomers ofvary-
ing degrees oftoxicity. Thus far, these isomers have not
been tested for their immunotoxic effects. The PBB
mixture itself has, however, been shown to cause
atrophy ofthe thymus and spleen in laboratory animals
and to affect the immune response (25).
It has also been determined that exposure of 2,2',4,
4',5,5'-hexabromobiphenyl to ultraviolet light severely
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increases its toxicity (26). Similar photolysis products
have been identified in PBB-contaminated soil from
Michigan (27).
Reproduction
Although TCDD has been shown to produce cleft
palates in several strains of mice and subcutaneous
edema, hemorrhage, and dilated renal pelvises in rats
and mice, the other chemicals in this general group are
not teratogenic, but they are fetotoxic (1). Mixtures of
PCBs and PBBs have causes absorptions, abortions, and
stillbirths and reduced survival to weaning in rodents,
monkeys and mink. The monkey and the mink are
affected at much lower dosage levels (28). Again,
quantitative differences exist between different com-
mercialmixtures. Inmultigenerationreproduction stud-
ies (29), a dietary level of 500 mg/kg body weight of a
commercial PCB mixture of Aroclor 1260 has been
found to be the lowest dose to affect reproduction in
Sherman strain rats, but a dietary level of 20 mg/kg
affected reproduction when Aroclor 1254 was fed. Thus,
variation in the isomeric composition of different mix-
tures greatly influences results. Specific isomers *of
PBBs and PCBs have not been studied to any great
extent (14), except in relation to enzyme induction and
in in vitro tests. Since the isomeric composition ofthese
chemicals changes in the environment, studies with
commerical products may not be altogether relevant for
predicting human health effects resulting from environ-
mental exposure to these compounds. These chemicals
are excreted in milk. Excretion in milk depends on its
fat content, and the level of excretion would be much
higher in rodents with a fat milk content of 13 to 15%
than in humans, with 1 to 4%. Both species can,
however, eliminate a large proportion of their body
burden through milk and pass it on to their offspring.
All the compounds discussed here, including certain
homologs ofthe PBB mixture, are extremely persistent
in mammals. In a recent study, dams ofSherman strain
rats were given two doses of 200 mg/kg of PBB by
gavage during pregnancy. The offspring that were also
nursed by the treated dams still had measurable PBB
body burdens at the end of their life span (see also
carcinogenesis) (30). At this dosage level, both the
number of live pups born and the number surviving to
weaning were slightlyreduced. Similar studies have not
been conducted with PCBs.
Carcinogenesis
A number ofstudies have been conducted with TCDD
(31,32). Hepatocellular carcinomas and squamous carci-
nomas of the oropharynx and lungs were produced in
Sprague-Dawley rats at doses of0.1pzg/kg/day. At daily
doses of 0.07 pug/kg body weight, Osborne Mendel rats
developed hepatocellular carcinomas and tumors ofthe
thyroid. In Swiss mice, and B6C 3F1 mice, hepato-
cellular carcinomas were also produced, and after der-
mal exposure Swiss mice developed subcutaneous
sarcomas. Although TCDD causes a variety oftumors,
only liver tumors and-in one study-tumors of the
stomach have been induced with PCBs. Kimbrough et
al. (34) exposed female Shermanrats to dietary levels of
100 mg/kg Aroclor 1260 and found 26 hepatocellular
carcinomas in 184 exposed rats, whereas only one of173
controls had a hepatocellular carcinoma. In addition,
many exposed rats had neoplastic nodules. In a study
conducted by the National Cancer Institute (NCI) (32)
with Aroclor 1254, there were 24 animals per group.
Investigators gave three different dosage levels of 25,
50, and 100 ppm Aroclor 1254 to the rats over their life
span. About 17to20rats pergroup survived. At the low
dose, neoplastic nodules were seen in 5 males. At the
intermediate dose, they were present in 8, and at the
high dose, in 12. In the females at the low dose,
neoplastic nodules were present in 6; at the mid dose, in
9; and at the high dose, in 17. In males, one hepato-
cellular carcinoma was seen at the mid dose and two at
the higher dose. In the females, no hepatocellular
carcinomas were seen.
In the NCI study, a number of exposed rats had
adenocarcinoma of the stomach. Morgan et al. (35)
reexamined 191 stomachs of rats from this study, of
which 144 rats had been exposed to Aroclor 1254. With
different staining techniques, they found six adeno-
carcinomas in exposed rats, and observed a high
incidence of squamous metaplasia in the epithelium of
the stomach. Squamous metaplasia is associated with
the occurrence of adenocarcinoma in the stomach. The
rat strain used was Fisher F344. Adenocarcinoma of
the stomach in this rat strain is extremely rare, 1 in
1754 (0.05%). Therefore, the investigators concluded
that the likelihood of observing 6 adenocarcinomas in
144 rats was less than 0.05 (p<0.05). Preston et al. (36)
found that PCBs promoted the induction of cancer
initiated by diethyl nitrosamine.
In anadditional studyin Sprague-Dawley rats fed 100
ppm (100mg/kg) Aroclor 1260, inwhich 32male control,
49 female control, 46 male exposed, and 47 female
exposedratswereavailableformicroscopicexamination,
a high incidence of well-differentiated hepatocellular
carcinomas was found in female rats and a lower
incidence in males (37). In addition, a few Japanese
PCBs were shown earlier to cause liver tumors in
rodents (38,39).
As noted previously, PBBs are extremely persistent.
It was possible to give 2-month-old female Sherman
strain rats a single dose of 1000 mg/kg PBB by gavage
and stillfind PBB levels rangingfrom8.77to25.8mg/kg
in the liver on a wet weight basis about two years after
exposure. The lipid concentration in these livers ranged
from 1.9 to 7.3%. These rats had a 41.4% (24/58)
incidence oftrabecular carcinomas ofthe liver, whereas
the controls had none. Ifthe PBB was given in divided
doses of 100 mg/kg twice a week every 3 weeks for a
total of 12 doses, the incidence oftrabecular carcinomas
of the liver was higher (60.7%). Some hepatocellular
carcinomas were very anaplastic, and one metastasized
to the lungs (40). Others have also reported the induc-
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tion ofhepatocellular carcinoma in rats when PBB was
fed in the diet for 6 months (41). Particularly in female
rats, many of the animals with liver tumors also have
hepatic porphyria caused by the inhibition of uropor-
phyrinogen decarboxylase. However, the two processes
appear to be independent of each other. In a reproduc-
tion study in Sherman strain rats where the dams
received two doses of 200 mg/kg PBB by gavage, the
male offspring, at the end oftheir life span, had a 9.6%
(4/41) incidence of hepatocellular carcinoma and the
female offspring, an incidence of hepatocelular carci-
noma and the female offspring, and incidence of 5.9%
(3/51). No such tumors were seen in the controls, and
none ofthe exposed offspring had hepatic porphyria. In
addition to the hepatocellular carcinomas, neoplastic
nodules were observed in 17.6% exposed females and in
4.9% exposed male rats. All exposed rats gained less
weight, and the lifespan of the male rats appeared
reduced in that many male rats died earlier than the
controls (30). It is therefore possible to induce hepato-
cellular carcinomas in offspring of dams treated with
PBB. No such studies have been conducted with PCBs
to determine whethertransplacental andneonatal expo-
sure is associated with a reduced life span and an
increased incidence in cancer. This study tends to
support the claim (42) that promoters ofcarcinogenesis
accelerate aging and thus reduce the life span.
Human Studies
The discussion of human studies will be primarily
limited to PCBs and PBB.
Body Burdens
In the United States today the primary source of
PCB exposure for the general population is fish from
contaminated waters. In the past, some farm families
were exposed to PCB from dairy products. The PCBs
originated from paint used on the inside of silos. In
addition to this kind of environmental contamination,
workers who repair transformers and workers who
handle toxic wastes may be exposed. Until 1976,
occupational exposurealsooccurredthroughtheproduc-
tion of PCBs and the incorporation of PCBs into
transformers, capacitors and other commercial prod-
ucts.
Numerous investigators have reported PCB in human
tissues (43,44). Because of regulatory actions taken in
the United States, total environmental PCB contamina-
tion has dropped. However, it has been postulated that
this merely represents a shift to a higher concentration
of more toxic isomers and that for correlating PCB
exposure with health effects, total PCB levels in serum
or tissues are meaningless unless the isomeric composi-
tion ofthe PCBs have been characterized. Inthe United
States, according to CDC data, mean blood PCB levels
are about 5 to 7 ng/mL (pbb), although some patients
may have higher blood levels without any documented
unusual exposure. Levels in adipose tissue and in
human milk fat are 100 to 200 times as high, since PCBs
are highly lipid-soluble.
Recently, the predominantly black population of
Triana, a small rural southern town in the United
States, was studied (7,8). This population had had
excessive exposure to DDT residues through the con-
sumption ofcontaminated fish. Fish consumption corre-
lated positively with PCB blood levels and no other
source of PCB exposure could be established. These
researchers also noted that PCB serum levels increased
with age and that levels were lower in females of each
age group. Similar findings were made for DDT
residues. The serum cholesterol level was positively
associated with the log PCB level independent of age,
sex, fish consumption, body mass index, and alcohol
consumption. Rates ofborderline and definite hyperten-
sion for study participants were 30% higher than
expected on the basis of national rates (45). Log PCB
serum values made a significant contribution to explain-
ing the variability of log systolic and diastolic blood
pressure in multiple regression analysis (46).
In the United States, in males and females, median
total cholesterol levels increase with age from about 150
to 160mg/dL at age 20 to over200mg/dL at age 50. It is
not entirely clearhowmuchthe concentration ofPCB in
blood is influenced by the serum lipid content and
whether populations with inherently lower total serum
cholesterol levels would have a different PCB serum
adipose tissue ratio than populations consuming a
western diet. The age-associated increase in blood PCB
levels could be related to the long half-life ofsome PCB
isomers which are preferentially retained in mam-
mals (47), and as long as exposure continues, a true
steady state between intake and excretion is never
reached. Othervariables affecting bodyburdens maybe
differences in metabolism with age. In the Triana
studies (7,8) the blood levels oftotal DDT residues also
increased with age, and others have made similar
observations (48-50).
In a study of a population in Michigan (51), PCB
blood levels again increased with age and were lower in
females. This same population had exposure to PBB
over a 2-year period in 1973 and 1974. The 1977 serum
PBB levels in 3683 participants ranged from less than 1
to 3150 jug/l, with ageometric mean of4.1 ,ug/l. Females
had generally lower serum PBB levels than males, but
mean serum PBB levels did not increase with age. The
fact that PBB levels did not increase with age in the
same population as did the PCB does not support the
hypothesis of an age-related change in serum/adipose
partition for these halogenated hydrocarbons. Length
of exposure appears to be the determining factor (51).
The fact that PCB body burdens increase proportion-
ally to the length ofexposure is further supported by a
study in workers. Wolff et al. (52), found that the
partition in adipose tissue of approximately 120 to 160
times the plasma concentration is consistent with the
higher lipid content ofadipose tissue and that there is a
good correlation between blood and adipose tissue PCB
levels. Chase et al. (53) also found a positive association
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between length of employment and blood and adipose
tissue PCB levels.
Similarly, a significant correlation between serum
PBB and adipose tissue PBB was found (54). Pregnant
and nonpregnant women and chemical workers had
similar serum to adipose tissue concentration ratios,
which ranged from 1:140 to 1:260. Males from farms had
significantly different ratios of 1:325 to 329. There is no
obvious reason for these differences. In this study it
was also found that PBB concentration in cord blood
was one-tenth ofthat found in maternal serum. Human
milk lipids contained PBB 107 to 119 times the amount
present in maternal serum. All of these data suggest
that serum levels of these types of chemicals can be
considered to represent a fraction of the total body
burden. Ifthe serum concentrations are known, adipose
tissue levels or levels in other organs can be estimated.
Very few human tissue samples have been analyzed
forchlorinated dibenzodioxins. Most ofthe analyses have
been limited to the determination ofone isomer, 2,3,7,8-
tetrachlorodibenzodioxin. Concentrations ofthis isomer
in adipose tissue from the general population have been
nondetectable or in the low nanogram per kilogram
adipose tissue range. Since this compound is more polar
than PCB and PBB, partitioning between adipose
tissue liver and blood may be different, with less of a
gradient between adipose tissue and blood.
Epidemiology Studies
Partly because of the Yusho episode in Japan and
partly because ofthe animal toxicology data, a number
of cross-sectional studies have been conducted in work-
ers exposed to PCBs, and results of three mortality
studies have been published. In addition, surveys have
been conducted in populations that have had environ-
mental exposure. In all of these studies the number of
participants was limited (7,8,46,55-61), and most were
cross-sectional studies, which are limited in their ability
to evaluate chronic health effects.
In anumber ofstudies, apositive association between
results of one liver function test in particular, the test
for y-glutamyltranspeptidase, and PCB blood levels has
been found. In addition, a positive association also
seems to exist between blood PCB levels and either
triglyceride and/or cholesterol serum levels (7,53,56,62).
The significance ofthese findings is not clear. A possible
explanation is that the liver is impaired in its ability to
transport, metabolize, or in other ways handle lipids
properly. Increased serum cholesterol levels have also
beenreported in animalsfollowing exposure to PBB and
PCB (11), whereas serumtriglycerides were unaffected.
Bernert et al. (11) also found enhanced lipid peroxida-
tion. Noattempts havebeenmade to determine whether
these chemicals cause lipid peroxidation in humans.
Published reports have shown that these types of
compounds affect reproduction in animals but, except
for the studies ofYusho patients, there are nopublished
reports on how PCBs affect reproduction in humans.
Taylor (63) presented preliminary data of a comparison
study of neonatal birth weight and gestation period of
infants from women who worked in capacitor plants.
When these two outcomes were compared with those in
workers in the same plant who were not exposed to
PCBs, differences were noted. Although the exposed
group was small, the gestation periods were shorter,
and the birth weights lower. The lower birth weight
could be explained in part by the shorter gestational
period. The study emphasizes that reproductive out-
comes need further study.
Thus far, no such findings have been reported from a
study in a population inadvertently exposed to PBB in
Michigan (51). This exposure occurred in 1973 and 1974,
and the Michigan Department of Health, in collabora-
tion with the Centers for Disease Control, has enrolled
about 4000 people in a long-term prospective study,
begun in 1976. Blood PBB levels have been determined
for all participants, and data have been collected by
questionnaire. In addition, some participants have had
more in-depth studies, the results of which have not
been completely analyzed. No effects on reproductive
outcomes have been observed in this cohort, but the
number of newborns in this group has been small, and
many of the participants have had very low level
exposure. Other confounding variables, such as smok-
ing and alcohol consumption, may also contribute to
adverse reproductive outcomes. Another problem is
that exposure may not have been properly defined,
since some PBB isomers, particularly photolysis prod-
ucts, are much more toxic than other congeners of the
mixture. However, only total PBB levels have been
determined in the population, and no attempt has been
made to characterize the PBB. It is conceivable that
people with symptoms might have been preferentially
exposed to the more toxic isomers. Thus, correlating
symptoms with total PBB levels may not be valid.
In a study in which organochlorine compounds were
measured in patients who had died of cancer and
patients who died ofother diseases (64), higher concen-
trations ofPCB and DDE were found in the samples for
the cancer patients. The mean PCB adipose levels in 11
male cancer patients was 8.8 mg/kg and in 22 noncancer
patients, 5.9 mg/kg. Although these differences are not
large, they were statistically significant. Wassermann et
al. (64) reported an increased concentration of organo-
chlorine compounds in lipids extracted from malignant
breast tissue compared with those from adjacent,
apparently normal breast tissue. Many factors, such as
age nutritional status, medications and precision ofthe
analytical methods, can influence levels of organochlo-
rine in tissue. The significance of these observations is
not clear, particularly since they are within the range of
levels normally observed in the general population.
Only three attempts have been made to determine
whetherexposure toPCBs causes anincreasedincidence
ofcancer. First, a retropsective mortality study of2567
workers in two capacitor plants was conducted by
Brown et al. (60). There were relatively few deaths
(163), which severely limited the statistical power ofthe
study, and the average follow-up was only 15 years,
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whereas latency periods of 20 to 30 years are not
uncommon for cancer deaths. The power ofthe study to
detect, for instance, a twofold increase in liver cancer
was approximately 13%. Over 50% of the sample had
exposure to PCB for only 2 years or less. Deaths from
liver cancer, cirrhosis ofthe liver and rectal cancer were
slightly higher than expected, but this was not statisti-
cally significant for both sites combined. The observed
increase for cancer of the rectum was statistically
significant amongfemales atone oftheplants. Additonal
mortality studies are in progress, but results are not yet
available. Second, Bahn et al. (59) reported earlier
three melanomas and two carcinomas ofthe pancreas in
41 refinery plantemployees and 51 researchanddevelop-
ment workers. This incidence was significantly higher
than expected. The cohort was again rather small, and
these workers had also had exposure to otherchemicals.
Third, Bertazzi et al. (61) reviewed the mortality of
290 males and 1020 females who had worked for 6
months or more in capacitor production. Males had a
statistically significant increased number ofdeaths from
all neoplasms. When analyzed by organ system, deaths
fromneoplasms ofthedigestive system, theperitoneum,
the lymphatic, and hematopoietic tissues were higher.
Among females, all causes of deaths were significantly
elevated. However, the actual numbers in this study
were small, and further studies are needed to substanti-
ate these findings.
Occasionally, in spite of the documented toxicity in
animals, it is suggested that chloracne is the only
established health effect in humans following exposure
to TCDD.
When such statements are made, findings, such as
porphyria cutanea tarda (66,67) and other systemic
health effects (1) are largely ignored. However, it is not
clear whether TCDD causes porphyria cutanea tarda in
humans. Neither is it pointed out that in all of the
episodes where workers developed chloracne the actual
amount ofTCDD thatthey absorbed orwere exposed to
is unknown. Again, in each ofthese episodes, the actual
numbers of exposed workers are too small to yield
useful information about possible chronic health effects.
The largest of these followup studies was that of 121
workers by Zack and Suskind (68). The National Insti-
tute of Occupational Safety and Health has established
a registry of workers with chloracne for a prospective
followup study, and the World Health Organization will
follow all such workers prospectively on a worldwide
basis. Virtually no information is available in the
literature on the other chlorinated dibenzodioxins.
Occasionally, chloracne and respiratory symptoms have
been reported in workers exposed to pentachlorophe-
nols (69), but it is not known to what extent and with
what isomers of chlorinated dibenzodioxins and chlori-
nated dibenzofurans the pentachlorophenols were
contaminated.
Hardell et al. (70) and Erikson et al. (71) conducted
two case control studies in Sweden and reported an
increased risk ofsoft tissue sarcomas in men who were
exposed either to trichlorophenols or to phenoxy herbi-
cides during their application. These authors also
reported a third case control study from Sweden which
suggests that phenoxy acids and chlorophenols may also
predispose to Hodgkin's lymphoma, but as yet there is
little support for this theory from other sources (72).
The Swedish studies were recently summarized and
discussed by Coggon and Acheson (73), who concluded
that "Further research is urgently needed to confirm or
refute these associations, to define the extent ofthe risk
(if any) and to identify the carcinogen(s)"
In the U. S. the Swedish results could not be
substantiated by Milham (74) but are supported by
results (75,76) in production workers. In the U.S., four
followup studies were conducted among workers ex-
posed to 2,4,5-trichlorophenol or 2,4,5-T. Each ofthree
cohorts had one death due to soft tissue sarcoma.
Honchar and Halperin (75) reviewed the four studies
and noted that in the four merged cohorts there were a
total of 105 deaths, three of which (2.9%) were due to
soft tissue sarcoma. Based on national rates ofdeath for
men aged 20 to 80, only 0.07% of deaths due to soft
tissue sarcoma would have been expected. Recently
another person in one of the four cohorts died due to a
soft tissue sarcoma (76), bringing the total to four
deaths due to soft tissue sarcoma in the four merged U.
S. cohorts. Microscopic review of tissue sections from
these tumors and three additional cases was recently
done. Two of the four cases with documented evidence
ofexposure and three additional cases that did not have
documented evidence of exposure were confirmed to
represent soft tissue sarcoma (77). Further large epide-
miology studies must be completed before the soft
tissue sarcoma issue can be resolved.
Since exposure to PBB tookplace only about 10 years
ago, the follow-up period in the Michigan cohort is too
short for results to be meaningful. In addition, the
actual number ofparticipants that are followed may not
be large enough to detect smallincreases in cancer. Since
the cohort is composed of participants who have been
exposed to widely varying amounts of PBB, this
becomes even more unlikely.
Conclusions
Animal studies seem to indicate that PCB, PBB, and
related compounds severely affect reproduction, are
carcinogenic-most likely acting as promoters-and
have immunotoxic effects. They also seem to cause lipid
peroxidation, increase serum cholesterol levels, and, in
some species, produce liver toxicity.
In humans, no adequate studies have been conducted
to judge whether long-term exposure to PCB is associ-
ated with cancer, nor have any reports been published
which have properly studied reproductive outcomes of
highly exposed females. On the other hand, it has been
determined that as long as exposure to PCB occurs,
body burdens will increase and the more toxic conge-
ners of the mixture will be preferentially retained.
Higher blood PCB levels are associated with higher
serum triglyceride and/or cholesterol levels, and in a
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study in which blood pressure was measured, high
blood pressure was associated with higher blood PCB
levels. It is important that additional studies be done
with sufficient statistical power to detect an increase
(doubling) in cancer. This will probably be possible only
ifa number ofexposed cohorts are combined. Consider-
ation should be given to establishing such a group
among highly exposed sports fishermen and their
families, since their exposure would be consistent with
environmental rather than occupational exposure. Re-
productive outcomes might also be more easily studied
in such groups.
Hypertension is very prevalent in the United States
and greatly influenced by lifestyle. Studies are needed
to determine the significance ofthe association between
blood PCB levels and elevated blood pressure.
Other well-designed studies are needed to determine
the human health effects ofchlorinated dibenzodioxins.
Use oftrade names is for identification only and does not constitute
endorsement by the Public Health Service orby the U.S. Department
of Health and Human Services.
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